ARHGDIB and metastatic malignant neoplasm in the lymph nodes: Hu et al identified a biphasic pattern of increased RhoGDI2 expression with breast hyperplasia, but decreased expression with progression and lymph node metastasis using IHC staining in 71 patients (13).